Valuation Provectus Biopharmaceuticals, Inc.

Stocks

Market Closed - OTC Markets 22:37:28 02/06/2026 +03			5-day change	1st Jan Change
0.0620 ^USD	-7.32%		+24.00%	+10.91%

08-13	Provectus Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-07	Provectus Biopharmaceuticals, Inc. Highlights Peer-Reviewed Study Demonstrating Opposing Mechanistic Effects Of Rose Bengal Sodium At The Same Dose	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	23.43	23.07	45.43	40.27	50.48	23.49
Change	-	-1.55%	96.93%	-11.35%	25.33%	-53.46%
Enterprise Value (EV) ¹	47.13	24.13	47.59	43.22	53.35	26.22
Change	-	-48.8%	97.24%	-9.18%	23.43%	-50.85%
P/E	-3.44x	-4.05x	-12.8x	-13x	-10.6x	-4.33x
PBR	-0.77x	-5.48x	-7.27x	-5.29x	-8.45x	-3.72x
PEG	-	0.2x	0.3x	1x	-0.2x	-0.3x
Capitalization / Revenue	-	-	45,934,892x	72,213,378x	81,789,566x	69,899,095x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-10x	-5.21x	-14.1x	-17.4x	-13.5x	-5.41x
EV / EBIT	-9.55x	-5.2x	-14x	-17.3x	-13.5x	-5.41x
EV / FCF	44.5x	-3.48x	-39.6x	-37.2x	-18.2x	-19.6x
FCF Yield	2.25%	-28.8%	-2.53%	-2.68%	-5.5%	-5.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.017	-0.0136	-0.008474	-0.007393	-0.0113	-0.0129
Distribution rate	-	-	-	-	-	-
Net sales	-	-	0.989	0.5577	0.6171	0.3361
EBITDA ¹	-4.694	-4.628	-3.38	-2.489	-3.939	-4.842
EBIT ¹	-4.936	-4.641	-3.391	-2.498	-3.946	-4.844
Net income ¹	-6.678	-5.54	-3.555	-3.102	-4.762	-5.431
Net Debt ¹	23.7	1.061	2.163	2.95	2.877	2.727
Reference price ²	0.0584	0.0550	0.1083	0.0960	0.1201	0.0559
Nbr of stocks (in thousands)	401,232	419,447	419,497	419,522	420,280	420,280
Announcement Date	3/2/21 A	3/29/22 A	3/30/23 A	3/28/24 A	3/28/25 A	3/26/26 A

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PROVECTUS BIOPHARMACEUTICALS, INC.	-	-	-	-	21.01M
WUXI APPTEC CO., LTD.	20.03x	7.14x	14.3x	1.48%	68.92B
ARGENX SE	27.94x	7.65x	24.01x	0.05%	51.9B
LONZA GROUP AG	34.21x	6.11x	18.26x	0.95%	48.73B
IQVIA HOLDINGS INC.	33.07x	3.27x	14.12x	-.--%	43.13B
REVOLUTION MEDICINES, INC.	-20.06x	203.22x	-21.36x	-.--%	41.48B
BEONE MEDICINES AG	46.56x	5.29x	29.06x	-.--%	39.96B
CELLTRION, INC.	26.85x	7.63x	19.75x	0.4%	30.6B
WUXI BIOLOGICS (CAYMAN) INC.	30.04x	6.38x	16.56x	-.--%	26.01B
BIONTECH SE	-13.53x	5x	-6.04x	-.--%	22.27B
Average	20.57x	27.97x	12.07x	0.32%	37.3B
Weighted average by Cap.	22.13x	28.09x	13.15x	0.44%